Search

Your search keyword '"Buggisch, Peter"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Buggisch, Peter" Remove constraint Author: "Buggisch, Peter" Topic chronic hepatitis c Remove constraint Topic: chronic hepatitis c
12 results on '"Buggisch, Peter"'

Search Results

1. Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry.

2. Late presentation of chronic hepatitis C patients in the era of direct‐acting antivirals—Data from the German Hepatitis C‐Registry.

3. The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R).

4. Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.

5. Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance‐associated substitutions.

6. Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection.

7. Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs.

8. Real‐world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1‐ and 4‐infected patients with diverse comorbidities and comedications: A pooled analysis of post‐marketing observational studies from 13 countries

9. Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA.

10. Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R).

11. Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.

12. THU-161-Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C treated with DAAs: Results from the German hepatitis C registry (DHC-R).

Catalog

Books, media, physical & digital resources